Efficacy and Safety of Omalizumab in Patients With Severe Persistent Asthma
Clinical trial NCT00046748 · COMPLETED
Trial details
- NCT number
- NCT00046748
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-12-01
- Primary completion
- 2004-04-01
- Enrollment
- 484
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.